Turn Your Existing Genomic Data
Into a Revenue Stream
Monetize de-identified patient data without losing ownership, jurisdiction, or compliance. Pan.bio helps hospitals unlock value from data that's currently sitting unused, while keeping every patient record inside your own infrastructure.
The Challenge
The Problem for Hospitals
Hospitals generate massive volumes of data through routine clinical genomics. Once the clinical report is delivered, that data becomes a dormant cost center, stored, secured, but never put to further use. The storage bills keep accumulating. The insights stay locked. And meanwhile, pharma R&D teams are paying for exactly the kind of real-world data your institution already has.
The problem isn't that the data isn't valuable. It's that hospitals have had no compliant, scalable way to unlock that value, without losing ownership, running afoul of data governance, or compromising patient privacy.
How Pan.bio Helps
The capabilities behind the difference
Pan.bio Patient Cohorts turns existing clinical genomic data into a revenue-generating asset, without adding sequencing cost, losing data ownership, or compromising compliance:
Data assessment
Pan.bio inventories your existing data assets, genomic, clinical, imaging, proteomic, and phenotype annotations.
Structuring and standardization
Data is mapped to recognized ontologies (HPO, ICD-10, LOINC) and standard genomic formats for consistency across institutions.
Local de-identification
Patient data is de-identified per HIPAA and local regulations. All processing happens locally, data doesn't leave the institution during this phase.
Marketplace listing
The de-identified cohort is published with metadata (disease focus, data modalities, patient count, completeness score) visible to researchers.
Revenue on every access
When researchers license access, the provider earns a majority share of the fee on every access event.
Beyond the Marketplace
How hospitals also use Pan.bio for internal analysis
-
Run validated nf-core pipelines for RNA-seq, variant calling, single-cell, and more, without building internal bioinformatics infrastructure
-
Notebooks with BioMind for custom analyses and internal research projects
-
In-country deployment with tenant isolation and full audit trails
-
VAIC integration for clinical variant interpretation and classification
What You Gain
Real outcomes, not just features
Tangible results from teams that moved their genomic work onto Pan.bio.
-
A new revenue stream from existing data, no additional sequencing cost required.
-
Full data ownership and jurisdiction, data stays under the provider's control at every step.
-
Compliance maintained by architecture, in-country processing, tenant isolation, and Trusted Research Environment model.
-
Recurring revenue per cohort, the same cohort can be licensed to multiple researchers simultaneously.
-
Zero upfront cost, Pan.bio handles platform infrastructure and researcher acquisition.
-
Internal analysis capabilities, use the same platform for your own research and clinical workflows.
Enforced at the infrastructure level, your data stays in your jurisdiction, always.
Ready to Unlock Your Hospital's Data Value?
Whether you're looking to monetize existing data or modernize your clinical research infrastructure, Pan.bio works with your team, your compliance requirements, and your timeline.
No credit card required · Start in minutes